News & Events about Ideaya Biosciences Inc.
IDEAYA Biosciences, Inc. (NASDAQ:IDYA Get Rating) Stock analysts at Capital One Financial issued their FY2027 EPS estimates for shares of IDEAYA Biosciences in a report issued on Tuesday, January 24th. Capital One Financial analyst Z. Jallah forecasts that the company will earn $1.90...
IDEAYA Announces Pricing of Public Offering of Common Stock IDEAYA Announces Pricing of Public Offering of Common Stock PR Newswire SOUTH SAN FRANCISCO, Calif., Sept. 14, 2022 SOUTH SAN FRANCISCO, Calif., Sept. 14, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc.(Nasdaq: IDYA) today announced the...
IDEAYA Biosciences to Participate in Investor Conferences in September 2022 IDEAYA Biosciences to Participate in Investor Conferences in September 2022 PR Newswire SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ...
Ticker Report
10 months ago
Wedbush restated their outperform rating on shares of IDEAYA Biosciences (NASDAQ:IDYA Get Rating) in a report published on Wednesday morning, MarketBeat.com reports. The brokerage currently has a $34.00 price target on the stock. Wedbush also issued estimates for IDEAYA Biosciences Q1...